Safety and Effectiveness of U‐500 Insulin Therapy in Patients with Insulin‐Resistant Type 2 Diabetes Mellitus
Authors:
- 1 July 2011
- journal article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 31 (7) , 695-702
Abstract
Study Objective. To assess the safety and effectiveness of highly concentrated U‐500 regular insulin in patients with insulin‐resistant type 2 diabetes mellitus who were switched from U‐100 insulin.Design. Retrospective cohort study.Setting. Outpatient diabetes management clinic.Patients. Twenty‐one adults with poorly controlled type 2 diabetes and insulin resistance who were referred to the clinic between July 1, 2007, and June 30, 2008, and whose therapy was changed from large doses of U‐100 insulin to U‐500 insulin.Measurements and Main Results. Demographic and clinical data were collected through a computerized medical record system. Insulin resistance was defined as a requirement of more than 200 units/day of insulin and more than 100 units/injection. The primary outcome was the change in hemoglobin A1c (A1C) after switching from any type of U‐100 insulin to stabilization with U‐500 highly concentrated regular insulin. Secondary outcomes were the changes in number of daily insulin injections, daily insulin dose, and body weight. With use of U‐500 insulin, patients were able to achieve an average reduction in A1C of 1.7% (pConclusion. In patients with insulin‐resistant diabetes who have requirements of more than 200 units/day or 100 units/injection, use of U‐500 regular insulin provided the same or better glucose control compared with U‐100 insulin, with fewer daily injections and reduced injection volume. Although this drug represents an excellent treatment option, its safe use requires an experienced physician, a motivated and cooperative patient, and a dynamic diabetes management team.Keywords
This publication has 22 references indexed in Scilit:
- Prevalence and Trends in Obesity Among US Adults, 1999-2008JAMA, 2010
- High-dose Insulin Therapy: is it Time for U-500 Insulin?Endocrine Practice, 2009
- Preventing Harm from High-Alert MedicationsThe Joint Commission Journal on Quality and Patient Safety, 2007
- Clinical Experience With U-500 Regular Insulin in Obese, Markedly Insulin-Resistant Type 2 Diabetic PatientsDiabetes Care, 2006
- Use of U-500 Regular Insulin in Type 2 DiabetesDiabetes Care, 2006
- The medical complications of obesityQJM: An International Journal of Medicine, 2006
- Analysis of Effectiveness of Human U-500 Insulin in Patients Unresponsive to Conventional Insulin TherapyEndocrine Practice, 2005
- Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001JAMA, 2003
- Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigsDiabetes Research and Clinical Practice, 2000
- A change to 100-unit insulin dosage will reduce errors.BMJ, 1981